RIBOMETRIX PARTNERS WITH WESTWOOD & WILSHIRE TO FILL VICE PRESIDENT - LEAD DISCOVERY AND RESEARCH OPERATIONS

William Janzen has joined Ribometrix as their new Vice President – Lead Discovery & Research Operations. Mr. Bill Janzen joins Ribometrix following 30 years of experience across over 500 drug discovery projects. His experience in strategic lead generation activities spans academia, start-up ventures and large pharmaceutical companies. He has held executive and operational positions including executive director of lead generation at Epizyme, director of assay development and compound profiling at the University of North Carolina, president and chief operating officer of Amphora Discovery and director of lead generation technologies at Eli Lilly and Company.

The search was successfully led by Tamir Halaban at Westwood & Wilshire.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.